You are here: Industry Insights > gene

News List

Making Sense of Antisense: The Power of Gene Silencing February 11, 2025
This article explores antisense oligonucleotides (ASOs) in gene silencing, covering their mechanism, development, applications, pros and cons, and future delivery challenges.
Top Generalizable Antivirals for Stockpiling in Emergencies: A Review and Gap Analysis David Orchard-Webb
February 06, 2025
Reviews top generalizable antivirals for emergency stockpiling, analyzes their pros & cons, and points out gaps in antiviral stockpile.
The Curtain Has Risen on the Competition for the First Generic Drug, so What Other Innovative Drugs in the Rare Disease Field Can We Look Forward to? Xiaobin
January 23, 2025
The CDE website shows Qilu Pharmaceutical applied for the marketing of nusinersen generic. Once controversial for high price, it treats SMA. Now many firms are involved, and SMA treatment progresses.
Regenerative Medicine and Drug Development: The Intersection of Stem Cells and Biotech Nurah Ekhlaque
January 17, 2025
Explore how regenerative medicine and biotech are transforming drug development with stem cell therapies, personalised treatments, and innovative solutions.
Cell and Gene Therapy Manufacturing: Operational Challenges and Strategic Considerations Neeta Ratanghayra
December 20, 2024
Producing CGTs requires highly specialized infrastructure, precise processes, and significant investments, making the manufacturing landscape both complex and costly.
Navigating the Neurodegenerative Crisis: A Multifaceted Approach Shruti Talashi
December 09, 2024
Overtaking more established issues like cancer and heart disease, neurological problems have become a major worldwide health concern.
Making Cell and Gene Therapy Affordable Suzanne Elvidge
November 04, 2024
Cell and gene therapies (CGTs) have revolutionised medicine, providing personalised and targeted treatment for life-limiting diseases from genetic disorders to hard-to-treat cance.However, these cutting-edge therapeutics can come with a high price tag.
Touchlight to Supply GMP dbDNA to Support University of Nottingham’s Clinical Study for a Next-Generation Vaccine for Zika Virus Biotech Newswire
August 22, 2024
Touchlight announced the clinical supply of its proprietary dbDNA™ to the University of Nottingham for research and development of a next-generation DNA vaccine targeting the Zika virus.
Gene Editing Destiny: The CRISPR Revolution and Beyond Shruti Talashi
August 01, 2024
Genome editing has the potential to eradicate hereditary illnesses, improve human potential, and transform biotechnology and agriculture with continued research and development.
British Journal of Cancer: Zurletrectinib Is a Next-Generation TRK Inhibitor With Strong Intracranial Activity Against NTRK Fusion-Positive Tumors With On-Target Resistance to First-generation Agents July 31, 2024
Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumors with on-target resistance to first-generation agents.